Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (1268)	9/5/2000 8:49:35 AM
From: scott_jiminez	Read Replies (1) \| Respond to of 4474

Another in a long line of papers published in top line journals displaying impeccable research. This is an especially timely publication in light of all the recent interest - and growing prospects - in the utilization of stem cells. Blau/Ariad has once again shown why RAPID/ARGENT is likely to become a multi-billion dollar platform in the future. Perhaps the real take home message from this paper is a solidification of the cumulative evidence that this 'future' may occur quite a bit earlier than previously perceived.